Volume 13, Number 10—October 2007
Compliance with Exclusion Requirements to Prevent Mumps Transmission
To the Editor: Control of communicable diseases often relies in part on school and workplace exclusion. Exclusion policies are also likely to play a role in pandemic influenza control and currently are used as policy for control of several vaccine-preventable diseases, including mumps (1). Mumps virus is typically present in saliva from 2–3 days before to 4–5 days after onset of parotitis. However, virus has been isolated from saliva as early as 6 days before and as late as 9 days after the first signs of salivary gland involvement (2).
In Illinois, persons with mumps are excluded from school and the workplace for 9 days after onset of parotitis (3) to reduce transmission of mumps virus. However, exclusion policy is not consistent among all states. For example, persons diagnosed with mumps in Iowa are excluded from school and the workplace for 5 days, whereas persons with mumps in New York and California are excluded for 9 days.
Illinois experienced a mumps outbreak during 2006 that resulted in 796 cases. We describe a telephone survey administered during April–June 2006, to a convenience sample of 174 persons >9 days after onset of parotitis during this outbreak to assess compliance with school and workplace exclusion requirements. The survey response rate was 68% (174/257).
Among 94 (54%) persons with mumps who had attended school, 85 (93%) of 91 spent time at home after they began experiencing parotitis, and 6 (7%) of 91 did not stay home from school. Most persons were told by local health department staff, student health services staff, or their medical provider to remain at home for 9 days. Among persons with mumps who spent some time away from school, 48 (56%) of 85 remained at home for >9 days. However, 37 (44%) of 85 persons did not remain at home for the entire exclusion period (median 5 days; range 1–8 days). Among 111 (64%) persons who worked outside the home, 93 (87%) of 107 spent time at home after they began experiencing parotitis.
Among persons who spent time away from work, 53 (57%) of 93 remained at home for >9 days. However, many persons (41%, 38/93) remained at home for fewer than the 9 days required by the state (median 5 days, range 1–8 days) after onset of parotitis. Reasons for complete noncompliance (not remaining at home from work during any part of the exclusion period) included not feeling ill enough to remain at home (50%, 7/14) and not receiving a diagnosis until after the exclusion period had elapsed (36%, 5/14) (Table). Because almost 80% of these noncompliant persons acknowledged being told not to work, lack of such instruction did not play a major role in this subset of cases.
Despite public health control measures, including expanded vaccination recommendations (4) and school and workplace exclusion, mumps cases in Illinois increased 90% from 419 during January 1, 2006, through May 17, 2006, to 796 through December 31, 2006. Given limited resources of local health departments, monitoring and ensuring compliance with exclusion control measures are likely to be a barrier in control of mumps, and these difficulties should be recognized as a potential issue in pandemic influenza planning. Additional studies targeting reasons for failure to comply and how to improve compliance will be useful preparedness activities.
An examination of whether exclusion for 9 days rather than only 5 days is a more effective mumps transmission control measure is also needed, given the difficulty with ensuring complete compliance for the full 9 days. Evidence for 9 days of shedding of mumps virus was based on a small number of experimentally infected children (N = 15), 8 of whom were asymptomatic (2). However, mumps exclusion policy states that 9 days is needed for persons with symptoms of parotitis. In addition, the population studied included no specimens from adults, although the exclusion policy derived from these data applies to persons of all ages. Finally, exclusion policy based only on parotitis may be feasible but would not affect persons with subclinical and nonspecific clinical infections who may shed mumps virus. A uniform evidence-based policy for exclusion is needed.
We thank Kae Hunt for provision of mumps surveillance data.
This study was supported in part by Centers for Disease Control and Prevention/Council of State and Territorial Epidemiologists Cooperative Agreement U60/CCU007277.
- Richardson M, Elliman D, Maguire H, Simpson J, Nicoll A. Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in school and preschools. Pediatr Infect Dis J. 2001;20:380–91.
- Henle G, Henle W, Wendell KK, Rosenberg P. Isolation of mumps virus from human beings with induced apparent or inapparent infections. J Exp Med. 1948;88:223–32.
- Joint Committee on Administrative Rules. Control of communicable diseases code. 2002. [cited 2006 Dec 15]. Available from http://www.ilga.gov/commission/jcar/admincode/077/077006900C05500R.html
- Centers for Disease Control and Prevention. Update: mumps activity—United States, January 1–October 7, 2006. MMWR Morb Mortal Wkly Rep. 2006;55:1152–3.
- Table. Reasons reported by 14 persons with mumps for not remaining home from work for any part of the exclusion period
Suggested citation for this article: Borchardt SM, Rao P, Dworkin MS. Compliance with exclusion requirements to prevent mumps transmission [letter]. Emerg Infect Dis [serial on the Internet]. 2007 Oct [date cited]. Available from http://wwwnc.cdc.gov/eid/article/13/10/07-0117
Please use the form below to submit correspondence to the authors or contact them at the following address:
Stephanie M. Borchardt, Fargo Veterans Administration Medical Center, 2101 Elm St N (151), Fargo, ND 58102, USA;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 02, 2010
- Page last updated: July 02, 2010
- Page last reviewed: July 02, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)